Inventor · disambiguated record
David E. Pereira
Also filed as: PEREIRA DAVID · PEREIRA DAVID E · PEREIRA DAVID EUGENE
21 granted patents·29 pending applications·275 citations·filing 1995–2022
95Inventor score
Files withCEMPRA PHARMACEUTICALS INC20PEREIRA DAVID E7BAXTER INT6TETARD INC5PONCE DE LEON HEALTH DESIGNATED ACTIVITY COMPANY4
Top patents by PatentIndex Score
50 records- 0194US7754902B2Ruthenium(II) catalysts for use in stereoselective cyclopropanationsVANDA PHARMACEUTICALS INC·Filed 2006·Granted Jul 13, 2010·37 cites·11 claims
- 0293US8796232B2Methods for treating resistant diseases using triazole containing macrolidesFERNANDES PRABHAVATHI B·Filed 2009·Granted Aug 5, 2014·23 cites·30 claims
- 0393US6670323B1Reduced side-effect hemoglobin compositionsBAXTER INT·Filed 2000·Granted Dec 30, 2003·104 cites·155 claims
- 0492US7211560B2Reduced side-effect hemoglobin compositionsBAXTER HEALTHCARE SA·Filed 2003·Granted May 1, 2007·51 cites·31 claims
- 0591US8759500B2Crystalline forms of a macrolide, and uses thereforCEMPRA PHARMACEUTICALS INC·Filed 2013·Granted Jun 24, 2014·12 cites·23 claims
- 0689US9051346B2Process for preparing triazole-containing ketolide antibioticsPEREIRA DAVID E·Filed 2011·Granted Jun 9, 2015·11 cites·35 claims
- 0776US8097738B2Ruthenium (II) catalysts for use in stereoselective cyclopropanationsPEREIRA DAVID E·Filed 2010·Granted Jan 17, 2012·2 cites·14 claims
- 0875US9937194B1Compounds and methods for treating inflammatory diseasesFERNANDES PRABHAVATHI·Filed 2012·Granted Apr 10, 2018·1 cites·29 claims
- 0974US9901592B2Methods for treating resistant diseases using triazole containing macrolidesCEMPRA PHARMACEUTICALS INC·Filed 2014·Granted Feb 27, 2018·1 cites·27 claims
- 1073US2022233699A1Compositions comprising fusidic acid and packages thereforARREVUS INC·Filed 2021·Application pending·0 cites
- 1172US8975386B2Crystalline forms of a macrolide, and uses thereforPEREIRA DAVID E·Filed 2011·Granted Mar 10, 2015·1 cites·14 claims
- 1270US9453042B2Process for the preparation of macrolide antibacterial agentsPEREIRA DAVID E·Filed 2008·Granted Sep 27, 2016·1 cites·25 claims
- 1365US2020040024A1Convergent processes for preparing macrolide antibacterial agentsTETARD INC·Filed 2019·Application pending·0 cites
- 1464US2020087335A1Processes for preparing macrolides and ketolides and intermediates thereforTETARD INC·Filed 2019·Application pending·0 cites
- 1564US2018369262A1Methods for treating resistant diseases using triazole containing macrolidesCEMPRA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1662US2020030448A1Compositions comprising fusidic acid and packages thereforARREVUS INC·Filed 2019·Application pending·0 cites
- 1760US9751908B2Convergent processes for preparing macrolide antibacterial agentsCEMPRA PHARMACEUTICALS INC·Filed 2014·Granted Sep 5, 2017·0 cites·17 claims
- 1860US2019209530A1Powder oral suspension formulations of antibacterial agentsCEMPRA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1959US2021070797A1Processes for preparing fluoroketolidesTETARD INC·Filed 2020·Application pending·0 cites
- 2059US2020276150A1Parenteral formulations of macrolide antibioticsTETARD INC·Filed 2019·Application pending·0 cites
- 2159US2019048035A1Processes for preparing macrolides and ketolides and intermediates thereforCEMPRA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2259US2019023731A1Convergent processes for preparing macrolide antibacterial agentsCEMPRA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2359US2019040096A1Crystalline forms of a macrolide, and uses thereforCEMPRA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2459US2019060457A1Compositions comprising fusidic acid and packages thereforCEM 102 PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2557US11802103B2Process of making calcium alpha-ketoglutaratePONCE DE LEON HEALTH DESIGNATED ACTIVITY COMPANY·Filed 2019·Granted Oct 31, 2023·0 cites·20 claims
- 2657US2019038653A1Compounds and methods for treating inflammatory diseasesCEMPRA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2756US2024360177A1Peptides with antimicrobial activitiesAIMMAX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2856US2014088062A1Compositions comprising fusidic acid and packages thereforPEREIRA DAVID E·Filed 2012·Application pending·0 cites
- 2955US8558017B2Ruthenium (II) catalysts for use in stereoselective cyclopropanationsPEREIRA DAVID E·Filed 2011·Granted Oct 15, 2013·0 cites·16 claims
- 3054US2019054059A1Parenteral formulations of macrolide antibioticsCEMPRA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3153US6018035AReagents for isotropic size enhancement of a peptide, protein, nucleotide or other substrateBAXTER INT·Filed 1997·Granted Jan 25, 2000·8 cites·4 claims
- 3253US2019241602A1Process for the preparation of macrolide antibacterial agentsCEMPRA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3352US2016244472A1Crystalline forms of a macrolide, and uses thereforCEMPRA PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3451US2015232500A1Processes for preparing macrolides and ketolides and intermediates thereforCEMPRA PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3551US2017224664A1Powder oral suspension formulations of antibacterial agentsCEMPRA PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3650US5981710ATherapeutic hemoglobin composition having isotropically increased sizeBAXTER INT·Filed 1997·Granted Nov 9, 1999·12 cites·9 claims
- 3750US2023255912A1Compositions and methods for treating crp-mediated diseasesPONCE DE LEON HEALTH DESIGNATED ACTIVITY COMPANY·Filed 2021·Application pending·0 cites
- 3850US2013045937A1Parenteral formulations of macrolide antibioticsCEMPRA PHARMACEUTICALS INC·Filed 2011·Application pending·0 cites
- 3949US10131684B2Process for the preparation of macrolide antibacterial agentsCEMPRA PHARMACEUTICALS INC·Filed 2016·Granted Nov 20, 2018·0 cites·26 claims
- 4049US6204254B1Biocompatible surfaces and a method for their preparationBAXTER INT·Filed 1997·Granted Mar 20, 2001·6 cites·16 claims
- 4146US10188674B2Parenteral formulations for administering macrolide antibioticsCEMPRA PHARMACEUTICALS INC·Filed 2013·Granted Jan 29, 2019·0 cites·28 claims
- 4246US2022265586A1Sustained-release compositions of alpha-ketoglutaratePONCE DE LEON HEALTH DESIGNATED ACTIVITY COMPANY·Filed 2020·Application pending·0 cites
- 4345US2019328759A1Parenteral formulations for administering macrolide antibioticsCEMPRA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 4442US6306828B1Enantiomerically-enhanced nutritional energy substratesBAXTER INT·Filed 1995·Granted Oct 23, 2001·5 cites·7 claims
- 4542US2018044365A1Processes for preparing fluoroketolidesCEMPRA PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4641US2021369750A1Nicotinamide riboside compositions for healthspan extensionPONCE DE LEON HEALTH DESIGNATED ACTIVITY COMPANY·Filed 2019·Application pending·0 cites
- 4740US9815863B2Hydrogen bond forming fluoro ketolides for treating diseasesPEREIRA DAVID E·Filed 2011·Granted Nov 14, 2017·0 cites·31 claims
- 4839US2003149307A1Process for the preparation of polyethylene glycol bis amineBAXTER INT·Filed 2002·Application pending·0 cites
- 4939US2020009173A1Triazole-containing macrolides and ophthalmic uses thereforTETARD INC·Filed 2018·Application pending·0 cites
- 5036US2018016226A14-azidobutylamines and processes for preparingCEMPRA PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David E. Pereira files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →